Sound Biologics
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21720 23rd Dr SE Ste 200, Bothell, Washi...Phone Number
(425) 398-2323Website
www.soundbiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sound Biologics
Sound Biologics specializes in developing innovative antibody combination therapies aimed at treating cancer, inflammatory, and autoimmune diseases. Their proprietary MabPair and Bispecific Platforms enable the creation of synergistic antibody combinations that enhance treatment efficacy while reducing costs. The company is committed to advancing therapies that improve human health and accessibility, with a focus on multi-pathway interventions. Led by a team with extensive experience in antibody engineering and immuno-oncology, Sound Biologics is actively progressing its pipeline to deliver impactful treatments to patients.Explore more
Sound Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sound Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Sound Biologics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Sound Biologics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sound Biologics has new funding data
Check out if Sound Biologics is spiking on competitors!
Sound Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Sound Biologics
Earning: See what the market has to say on Sound Biologics recently announced quarterly report
Product Launch: Get notified when Sound Biologics launches new products
Recommended Actions
Reach out to Masked Content who joined Sound Biologics as Masked Content
Find more new buyers
Compare Similar Companies to Sound Biologics
Compare insights from companies similar to Sound Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sound Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sound Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sound Biologics.
Sound Biologics Tech Stack
A closer look at the technologies used by Sound Biologics
Most Recent Scoops
Project
Product Development, Legal Affairs, Safety, Medical Research, Pharmaceuticals, Clinical Operations, Health & Safety, Regulations
Left Company
Executive Move
Funding
Sound Biologics has received an SBA PPP loan for $350,000 from Cache Valley Bank, supporting the retention of 26 jobs.
Funding
Sound Biologics News & Media
Sound Biologics Announces Presentations at ASCO 2022 Annual Meeting
PSB205/QL1706, a bifunctional anti-PD-1 and anti-CTLA-4 MabPair product, demonstrates anti-tumor effects with acceptable tolerability and manageable toxicity BOTHELL, WA, UNITED STATES, June 3, 2022 /EINPresswire.com/ -- Sound Biologics (Qilu Puget …Sound Biologics Announces Proof-of-Concept Success at AACR Annual Meeting
BOTHELL, Wash., April 13, 2021 /PRNewswire/ -- Qilu Puget Sound Biotherapeutic Corp. (Sound Biologics), an emerging biotechnology company focused on developing a novel MabPair™ platform for antibody-based combination therapies for the treatment of cancer, inflammation and autoimmune...Sound Biologics Announces FDA Allowance of its IND Application for PSB205, an Anti-PD-1/CTLA-4 MabPair, in Relapsed and Refractory Solid Tumors
SEATTLE, April 10, 2019 /PRNewswire/ -- Qilu Puget Sound Biotherapeutic Corp. (Sound Biologics), an emerging biotechnology company dedicated to developing next generation antibody combination therapies, today announced that U.S. Food and Drug Administration (FDA) has accepted the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sound Biologics
Sign Up For FreeTo access detailed company insights
Sound Biologics specializes in developing innovative antibody combination therapies aimed at treating cancer, inflammatory, and autoimmune diseases. Their proprietary MabPair and Bispecific Platforms enable the creation of synergistic antibody combinations that enhance treatment efficacy while reducing costs. The company is committed to advancing t... Read More
